13:30
#127 Nocturnal polyuria and nocturnal arginine vasopressin (AVP): a key factor in the patho-physiology of monosymptomatic nocturnal enuresis
Presenter: Diaa Abdel Fattah
Abdel Fattah D1, Ezzat M1, Shaker H1, Ismail M11. Faculty of Medicine, Ain Shams University, Cairo, Egypt
13:37
#128 Vesicostomy as a protection of the upper urinary tract on long follow up and the associated lifestyle adjustments of patient’s caretaker
Presenter: Carlos Arturo Levi D'Ancona
Dancona C1, Prudente A1, Reis L1, Franca R1, Miranda M1, Ikari O1, Junior W11. UNICAMP
13:45
#129 Interstim Implants in the Pediatric Population
Presenter: Durwood Neal
Neal D11. University of Missouri-Columbia
13:52
#130 ALTERED MODULATION OF ADRENERGIC SIGNALING BY SMOOTH MUSCLE CAVEOLAE IN DETRUSOR OVERACTIVITY
Presenter: Vivian Cristofaro
Cristofaro V1, Radisavljevic Z M1, Yalla S V1, Sullivan M P11. Boston VA Healthcare System, Harvard Medical School
14:00
#131 Microcirculation in the urinary bladder wall in OAB female patients
Presenter: Igor Kuzmin
Kuzmin I1, Al-Shukri S1, Lukina E1, Boriskin A11. St Petersburg State Medical Pavlov University, Urology Department
14:07
#132 Routine MSU culture in patients with symptoms of OAB may be missing many genuine infections
Presenter: Shozab Khan
Khasriya R1, Khan S1, Bignall J1, Lunawat R1, Malone-Lee J11. UCL
14:15
#133 BOTOX® FOR IDIOPATHIC OVERACTIVE BLADDER PATIENTS REFRACTORY TO ANTIMUSCARINIC THERAPY IN THE ABSENCE OF DETRUSOR OVERACTIVITY
Presenter: Angelo Gousse
Gousse A1, Barboglio P1, Cohen B1, Rodriguez D1, Caruso D11. University of Miami Miller School of Medicine
14:22
#134 Patient-selected goals in overactive bladder: a placebo controlled randomised double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence
Presenter: Rufus Cartwright
Cartwright R1, Srikrishna S1, Cardozo L1, Robinson D11. King's College Hospital